STATE OF NEW YORK
________________________________________________________________________
10521
IN ASSEMBLY
March 6, 2026
___________
Introduced by M. of A. HEVESI -- read once and referred to the Committee
on Health
AN ACT to amend the public health law, in relation to newborn screening
for CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Subdivision 1 of section 2500-a of the public health law is
2 amended by adding a five new paragraphs (l), (m), (n), (o) and (p) to
3 read as follows:
4 (l) Late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2).
5 (m) Mucopolysaccharidosis type IVA (MPS IVA).
6 (n) Mucopolysaccharidosis type VI (MPS VI).
7 (o) Mucopolysaccharidosis type VII (MPS VII).
8 (p) Fabry.
9 § 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD15047-01-6
